LUCIA NOVAK: Open Payments
NPI 1851361182 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$74,391 in 127 payments from 17 companies in 2025. Trend: 2023 $96,872 · 2024 $81,128 · 2025 $74,391
Speaker / faculty: $29,830Consulting: $24,388Travel & lodging: $11,376Food & beverage: $4,546Speaker / faculty: $4,251
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $34,530 |
| SANOFI-AVENTIS U.S. LLC | 33 | $25,609 |
| Abbott Laboratories | 27 | $12,965 |
| Corcept Therapeutics | 10 | $315 |
| BETA BIONICS, INC. | 3 | $204 |
| Madrigal Pharmaceuticals | 3 | $188 |
| Lilly USA, LLC | 8 | $146 |
| Amgen Inc. | 5 | $111 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
Products named: TZIELD, Ozempic, FREESTYLE LIBRE 3, Korlym, iLet Bionic Pancreas, REZDIFFRA, JARDIANCE, REPATHA.
Industry payments across MD — which companies pay providers there.
